LCM
IMGN

Legato Capital Management’s Immunogen Inc IMGN Stock Holding History

Legato Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-43,144
Closed -$685K – 634
2023
Q3 		$685K Buy
43,144
+15,161
+54% +$252K 0.1% 323
2023
Q2 		$528K Buy
+27,983
New +$330K 0.07% 411

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Legato Capital Management's IMGN Position: Q4 2023 in Review

Legato Capital Management sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 43,144 shares — an estimated $685K sold.

Legato Capital Management first reported a position in IMGN in Q2 2023 and held it in 2 quarters. The position peaked at $685K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Legato Capital Management reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Legato Capital Management sold 43,144 Immunogen Inc shares in Q4 2023, an estimated $685K.
  • Legato Capital Management first reported a position in Immunogen Inc in Q2 2023 and held it in 2 quarters.
  • Legato Capital Management's Immunogen Inc position peaked at $685K in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Legato Capital Management's 13F filing for Q4 2023, filed 16 Jan 2024.